VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

  • Etude concernée: MAPS
  • Auteurs / Authors: Levallet G, Dubois F, Elie N, Creveuil C, Brosseau S, Danel C, Scherpereel A, Lantuejoul S, Mazières J, Greillier L, Audigier-Valette C, Bergot E, Moro-Sibilot D, Molinier O, Léna H, Monnet I, Morin F, Gounant V, Zalcman G
  • Journal / Conference: Lung Cancer
  • Année / Year: 2023
  • PMID: 37393757
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/37393757/